Patents by Inventor John Shern

John Shern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid biopsy to detect cancer early and sensitively in patients with neurofibromatosis type 1
    Patent number: 12140595
    Abstract: Among the various aspects of the present disclosure is the provision of methods for detecting cancer in Neurofibromatosis Type 1 (NF1) patients.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: November 12, 2024
    Assignees: WASHINGTON UNIVERSITY, NATIONAL INSTITUTES OF HEALTH
    Inventors: Aadel Chaudhuri, Paul Jones, Jeffrey Szymanski, Angela Hirbe, Russell Sundby, John Shern
  • LIQUID BIOPSY TO DETECT CANCER EARLY AND SENSITIVELY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1
    Publication number: 20220334121
    Abstract: Among the various aspects of the present disclosure is the provision of methods for detecting cancer in Neurofibromatosis Type 1 (NF1) patients.
    Type: Application
    Filed: January 27, 2022
    Publication date: October 20, 2022
    Applicants: Washington University, NATIONAL INSTITUTES OF HEALTH
    Inventors: Aadel Chaudhuri, Paul Jones, Jeffrey Szymanski, Angela Hirbe, Russell Sundby, John Shern